Performance of China’s Pharmaceutical Industry in H1
‘China’s pharmaceutical industry witnessed good development momentum in the first half of 2005, with profits and sales concentrated in large enterprises.
Jiangsu Province in east China is leading the pharmaceutical industry with a profit of 2.947 billion yuan in the first half.
China’s Shandong Province registered 24.665 billion yuan (US$3 billion) in sales value in the period, ranking first in the country, surging by 49.81 per cent, 8 percentage points higher than in the first quarter.
Its profit jumped by 55.37 per cent, 11 percentage points more than in the first quarter.
The sales and profits in Jiangsu, Shandong and Zhejiang each accounted for at least 10 per cent of the total in the country, while the top 15 provinces monopolized 85.01 per cent of the sales and profits.
Powerful drug companies contribute more
– The top 100 enterprises generated a combined sales revenue of 93.63 billion yuan in the first six months, 47.4 per cent of the industry’s total. The Shanghai Pharmaceutical (Group) Co., Ltd. (SPGC) recorded the biggest sales of 10.38 billion yuan, followed by Guangzhou Pharmaceutical Holdings Ltd. (GPC) with 7.2 billion yuan.’
Read more at Performance of China’s Pharma Industry in H1
Recent Entries
- Sigma Pharmaceuticals year profit rises 27 pct
- South African citizens cheap drug guinea pigs
- Two drugs test victims face a year in coma
- Can drug companies improve their reputation?
- Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
- Pfizer’s Forecast Disappoints
- Pharmaceutical RFID Adoption Stalls
- Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
- GlaxoSmithKline unveils best results since merger
- Pfizer Sues Teva, Sandoz Over Zithromax